China Veterinary Medicine Market Report: Market Size & Forecast 2026

China commands the world's largest veterinary medicine market, underpinned by its position as the top global consumer of animal health products through 2030. The sector encompasses pharmaceuticals, vaccines, diagnostics, and feed additives serving a livestock sector whose output value reaches hundreds of billions of dollars annually. Official government statistics show ongoing investment in agricultural modernization and disease prevention infrastructure across the country.

• •The market reflects China's status as the world's largest consumer of veterinary antimicrobials, with consumption projected to remain dominant through 2030
• •Livestock output value and direct losses from disease outbreaks drive sustained spending on veterinary interventions and biosecurity measures
• •Ministry of Agriculture and Rural Affairs (MARA) regulatory frameworks govern product approvals, antimicrobial stewardship, and farming standards nationwide

Expanding meat consumption and the Chinese government's push toward agricultural industrial-scale production are primary catalysts for market expansion. Livestock sector modernization, combined with biosecurity mandates following African swine fever outbreaks, has accelerated adoption of veterinary pharmaceuticals, vaccines, and diagnostic tools. Rising consumer demand for safe animal protein and government quality-control initiatives further reinforce investment across the supply chain.

• •USDA analyses project sustained growth in China's livestock production, directly correlating with increased demand for veterinary medicines and preventive health products
• •African swine fever outbreaks prompted stricter biosecurity protocols and veterinary management interventions, expanding the market for vaccines, diagnostics, and antimicrobials
• •MARA targets for agricultural scale and efficiency drive consolidation in farming operations, boosting procurement of professional-grade animal health products

The market spans pharmaceuticals including antimicrobials and antiparasitics, vaccines, diagnostics, and feed additives, with pharmaceutical products representing the largest segment. Geographically, demand is concentrated in eastern and central provinces with dense livestock populations, though western regions are catching up through government-supported farming programs. Export-oriented production zones and integrated breeding operations increasingly adopt premium veterinary solutions aligned with international standards.

• •Pharmaceutical products dominate the market, with antimicrobials accounting for the largest share of veterinary medicine consumption globally
• •Livestock-intensive provinces in eastern China, particularly those supporting pork and poultry production, represent the highest concentration of veterinary product demand
• •Government rural development programs are expanding veterinary access in less developed western and central regions, diversifying the geographic distribution of market growth

What are the recent trends and outlook?

Antimicrobial stewardship and regulatory reform are reshaping product development and prescribing practices across the Chinese veterinary sector. Digitalization of livestock management, precision farming technologies, and expanded vaccine coverage against emerging diseases are expected to drive future growth beyond conventional pharmaceuticals. As China continues consolidating its position as the world's largest animal health market through 2030, innovation in biologics, diagnostics, and alternative health products will define competitive advantage.

• •MARA's antimicrobial reduction policies and phased restrictions on certain drug classes are accelerating development of vaccines, probiotics, and alternative disease prevention strategies
• •Advances in veterinary diagnostics and digital livestock monitoring are creating new revenue streams and improving disease surveillance capabilities
• •Continued industrialization of Chinese agriculture and growing consumer emphasis on food safety are projected to sustain above-average market growth through the decade